Document is current
Any future updates will be listed below
-
Authors
Li, Tianyi
Yang, Qiao
Acs, Balazs
Sifakis, Emmanouil G.
Toosi, Hosein
Engblom, Camilla
Thrane, Kim
Lin, Qirong
Mold, Jeff E.
Sun, Wenwen
Boyaci, Ceren
Steen, Sanna
Frisén, Jonas
Lagergren, Jens
Lundeberg, Joakim
Chen, Xinsong
Hartman, Johan
-
Funding
Funding for this research was provided by:
Cancerfonden
China Scholarship Council
MedTechLabs
Region Stockholm
Svenska Sällskapet för Medicinsk Forskning
Vetenskapsrådet (201806217_VR, 201806217_VR, 201806217_VR, 201806217_VR, 201806217_VR, 201806217_VR, 201806217_VR, 201806217_VR, 201806217_VR)
H2020 Marie Skłodowska-Curie Actions (844712)
Radiumhemmets Forskningsfonder
- License Information
-
More Information
Article History
Received: 27 May 2025
Accepted: 24 August 2025
First Online: 9 September 2025
Competing interests
: C.E., K.T., Q.L., J.E.M., J.F. and J.Lu. are inventors on the patent (US Patent no. US11692218B2) encompassing the spatial VDJ work. C.E. and K.T. are scientific consultants for 10x Genomics Inc., which holds IP rights to spatial VDJ technology. J.E.M. has stock in Pacific Biosciences. J.H. has obtained speaker’s honoraria or advisory board remunerations from Roche, Novartis, AstraZeneca, Pfizer, Eli Lilly, MSD, Sakura, and Gilead, and has received institutional research support from Cepheid, Novartis, Roche, MSD, and AstraZeneca. J.H. is co-founder and shareholder of Stratipath AB. The remaining authors declare no competing interests.
